USA TODAY | Vivus surges, Arena tumbles on diet drug MarketWatch SAN FRANCISCO (MarketWatch) â€" Vivus Inc. shares surged almost 10% on Wednesday after the company won key Food and Drug Administration approval for its obesity-management drug Qsymia. At the same time, Vivus's triumph was a blow to Arena ... Sector Snap: Ob esity drugmakers Vivus and Arena Vivus To Advance On Buyout Trade; Arena Takeout Unlikely Glory for Vivus After Arena - Analyst Blog |
Thursday, July 19, 2012
Vivus surges, Arena tumbles on diet drug - MarketWatch
houghtalingbaemo1268.blogspot.com
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment